PI
Amsterdam Cardiovascular Sciences
-
Imatinib treatment improves hyperglycaemic dysregulation in severe COVID-19: a secondary analysis of blood biomarkers in a randomised controlled trial
Duijvelaar, E., Pan, X., Bogaard, H. J., Eringa, E. C. & Aman, J., 1 Dec 2024, In: Critical Care. 28, 1, 65.Research output: Contribution to journal › Article › Academic › peer-review
-
Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19 (Genome Medicine, (2023), 15, 1, (22), 10.1186/s13073-023-01173-8)
COVIDeF Study Group, French COVID Cohort Study Group, CoV-Contact Cohort, COVID-STORM Clinicians, COVID Clinicians, Orchestra Working Group, Amsterdam UMC Covid-19 Biobank, NIAID-USUHS COVID Study Group & COVID Human Genetic Effort, Dec 2024, In: Genome Medicine. 16, 1, 6.Research output: Contribution to journal › Comment/Letter to the editor › Academic
-
Correction to: Mechanical stimulation of induced pluripotent stem cell derived cardiac fibroblasts (Scientific Reports, (2024), 14, 1, (9795), 10.1038/s41598-024-60102-w)
Bekedam, F. T., Smal, R., Smit, M. C., Aman, J., Vonk-Noordegraaf, A., Bogaard, H. J., Goumans, M. J., De Man, F. S. & Llucià-Valldeperas, A., Dec 2024, In: Scientific reports. 14, 1, 13264.Research output: Contribution to journal › Comment/Letter to the editor › Academic
- All publications